Volume 64, 2022-8-1, Pages i-159
Articles in this issue:
1. Editorial Board
2. Breast cancer in Woman Sitting Half-Dressed beside a stove (1658) by Rembrandt van Rijn
- Pages 134-135.
- Nerlich, Andreas G., DeWaal, Johann C., Donell, Simon T., and Bianucci, Raffaella.
- PDF
3. Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis
- Pages 7-18.
- Pathak, Neha, Sharma, Aparna, Elavarasi, Arunmozhimaran, Sankar, Jeeva, Deo, S.V.S., Sharma, Daya N., Mathur, Sandeep, Kumar, Sudhir, Prasad, Chandra P., Kumar, Akash, and Batra, Atul, MD DM.
- PDF
4. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review
- Pages 63-84.
- Fleming, Leanne, Agnew, Sommer, Peddie, Nicola, Crawford, Megan, Dixon, Diane, and MacPherson, Iain.
- PDF
5. Global guidelines for breast cancer screening: A systematic review
- Pages 85-99.
- Ren, Wenhui, Chen, Mingyang, Qiao, Youlin, and Zhao, Fanghui.
- PDF
6. Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy
- Pages 1-6.
- Yang, Libo, Shen, Mengjia, Qiu, Yan, Tang, Tingting, and Bu, Hong.
- PDF
7. Physical functioning, frailty and risks of locally-advanced breast cancer among older women
- Pages 19-28.
- Coleman, Chandler, Yan, Connie H., Ko, Naomi Y., Nabulsi, Nadia A., Hoskins, Kent F., Chiu, Brian C.-H., and Calip, Gregory S..
- PDF
8. Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer
- Pages 29-34.
- Van der Vorst, Aline, Kindts, Isabelle, Laenen, Annouschka, Neven, Patrick, Janssen, Hilde, and Weltens, Caroline.
- PDF
9. Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ
- Pages 35-40.
- Darvishian, Farbod, Wu, Yinxiang, Ozerdem, Ugur, Chun, Jennifer, Adams, Sylvia, Guth, Amber, Axelrod, Deborah, Shapiro, Richard, Troxel, Andrea B., Schnabel, Freya, and Roses, Daniel.
- PDF
10. Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
- Pages 41-46.
- Davey, Matthew G., Davey, Ciara M., Bouz, Luis, Kerin, Eoin, McFeetors, Carson, Lowery, Aoife J., and Kerin, Michael J..
- PDF
11. Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study
- Pages 50-55.
- Brunner, Christine, Emmelheinz, Miriam, Kofler, Ricarda, Abdel Azim, Samira, Lehmann, Marlene, Wieser, Verena, Ritter, Magdalena, Oberguggenberger, Anne, Marth, Christian, and Egle, Daniel.
- PDF
12. Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials
- Pages 56-62.
- Cui, Wanyuan, Phillips, Kelly-Anne, Francis, Prudence A., Anderson, Richard A., Partridge, Ann H., Loi, Sherene, Loibl, Sibylle, and Keogh, Louise.
- PDF
13. Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression
- Pages 100-111.
- Wildiers, Hans, Meyskens, Thomas, Marréaud, Sandrine, Lago, Lissandra Dal, Vuylsteke, Peter, Curigliano, Giuseppe, Waters, Simon, Brouwers, Barbara, Meulemans, Bart, Sousa, Berta, Poncet, Coralie, and Brain, Etienne.
- PDF
14. Management of HR+/HER2+ lobular breast cancer and trends do not mirror better outcomes
- Pages 112-120.
- Yaghi, Marita, MD, Bilani, Nadeem, MD, Dominguez, Barbara, MBA, Jabbal, Iktej Singh, MBBS, Rivera, Carlos, MD, Bou Zerdan, Maroun, MD, Li, Hong, MS, Saravia, Diana, MD, Stone, Elizabeth, MD, and Nahleh, Zeina, MD, FACP.
- PDF
15. Fertility preservation in patients of childbearing age treated for breast cancer: A nationwide cohort study
- Pages 121-126.
- Duraes, Martha, Rathat, Gauthier, Bringer-Deutsch, Sophie, Ranisavljevic, Noémie, Brouillet, Sophie, Defez-Fougeron, Christine, and Duflos, Claire.
- PDF
16. Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry
- Pages 127-133.
- Singer, C.F., Jahn, S.W., Rudas, M., Bago-Horvath, Z., Fitzal, F., Abete, L., Moinfar, F., Gnant, M., and Filipits, M..
- PDF
17. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials
- Pages 136-142.
- Pfaffendorf, Charlotte, Vonthein, Reinhard, Krockenberger-Ziegler, Katja, Dellas, Kathrin, Schreiber, Andreas, Uhlemann, Dorit, Dinges, Stefan, Würschmidt, Florian, Andreas, Peter, Weinstrauch, Evelyn, Eilf, Kirsten, Rades, Dirk, Höller, Ulrike, Combs, Stephanie E., Kazmierczak, Renata, Fehlauer, Fabian, Schreck, Ulrike, Zimmer, Jörg, Dunst, Jürgen, and Krug, David.
- PDF
18. Ovarian reserve in premenopausal women with breast cancer
- Pages 143-150.
- Zong, Xiangyun, Yu, Yang, Chen, Wenhu, Zong, Weiwei, Yang, Hongjian, and Chen, Xuan.
- PDF
19. Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study
- Pages 151-158.
- Gligorov, Joseph, Pivot, Xavier, Ataseven, Beyhan, De Laurentiis, Michelino, Jung, Kyung Hae, Manikhas, Alexey, Abdel Azim, Hamdy, Gupta, Kushagra, Alexandrou, Ari, Herraez-Baranda, Luis, Tosti, Nadia, and Restuccia, Eleonora.
- PDF
20. Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort study
- Pages 47-49.
- French, David P., McWilliams, Lorna, Howell, Anthony, and Evans, D Gareth.
- PDF
21. Meeting the proposal for service improvement for pregnant women with cancer
- Pages 159-159.
- Cardonick, Elyce, and Seidman, Lindsey.
- PDF